Similar to other forms of axonal Guillain-Barré syndrome, sensory nerves show reversible conduction failure in Fisher syndrome

Clinical Neurophysiology

Volumn 125, Issue 1, 2014, Pages 212-213

  Umapathi, Thirugnanam ^a   Sheng Jie Christen, Lim ^b   Yuki, Nobuhiro ^c  

^a National Neuroscience Institute   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c Dept Medicine Endocrinol Diabet   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE MOTOR AXONAL NEUROPATHY; ELECTRODIAGNOSIS; GUILLAIN BARRE SYNDROME; HOFFMANN REFLEX; HUMAN; LATENT PERIOD; LETTER; MEDIAN NERVE; NERVE CONDUCTION; NERVE CONDUCTION DISORDER; NERVE FIBER DEGENERATION; NERVE POTENTIAL; OPHTHALMOPLEGIA; PRIORITY JOURNAL; SENSORY NERVE; SPINAL GANGLION; SURAL NERVE; ULNAR NERVE; WALLERIAN DEGENERATION;

EVOKED POTENTIALS, SOMATOSENSORY; HUMANS; MILLER FISHER SYNDROME; NERVE FIBERS, MYELINATED; NEURAL CONDUCTION; SKIN;

EID: 84890188182     PISSN: 13882457     EISSN: 18728952     Source Type: Journal    
DOI: 10.1016/j.clinph.2013.05.029     Document Type: Letter

References (8)

1. Capasso M., Notturno F., Manzoli C., Uncini A. Involvement of sensory fibres in axonal subtypes of Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 2011, 82:664-670.
2. Chaudhry V., Cornblath D.R. Wallerian degeneration in human nerves: serial electrophysiological studies. Muscle Nerve 1992, 15:687-693.
3. Chiba A., Kusunoki S., Obata H., Machinami R., Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology 1993, 43:1911-1917.
4. Notturno F., Caporale C.M., Uncini A. Acute sensory ataxic neuropathy with antibodies to GD1b and GQ1b gangliosides and prompt recovery. Muscle Nerve 2008, 37:265-268.
5. Sekiguchi Y., Misawa S., Shibuya K., Mitsuma S., Hirano S., Ohmori S., et al. Patterns of sensory nerve conduction abnormalities in Fisher syndrome: more predominant involvement of group Ia afferents than skin afferents. Clin Neurophysiol 2013, 124:1465-1469.
6. Susuki K., Yuki N., Schafer D.P., Hirata K., Zhang G., Funakoshi K., et al. Dysfunction of nodes of Ranvier: a mechanism for anti-ganglioside antibody-mediated neuropathies. Exp Neurol 2012, 233:534-542.
7. Umapathi T., Tan E.Y., Kokubun N., Verma K., Yuki N. Non-demyelinating, reversible conduction failure in Fisher syndrome and related disorders. J Neurol Neurosurg Psychiatry 2012, 83:941-948.
8. Uncini A. A common mechanism and a new categorization for anti-ganglioside antibody-mediated neuropathies. Exp Neurol 2012, 235:513-516.